{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:00:24Z","timestamp":1793520024909,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Skeletal Muscle Research Center"},{"DOI":"10.13039\/100004329","name":"Genzyme Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ymgme.2016.12.004","type":"journal-article","created":{"date-parts":[[2016,12,11]],"date-time":"2016-12-11T15:01:08Z","timestamp":1481468468000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["The emerging phenotype of late-onset Pompe disease: A systematic literature review"],"prefix":"10.1016","volume":"120","author":[{"given":"Justin","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit K.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoheb B.","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Hobson-Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2016.12.004_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2051-5960-2-2","article-title":"The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients","volume":"2","author":"Feeney","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0010","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mus.21025","article-title":"Clinical features of late-onset Pompe disease: a prospective cohort study","volume":"38","author":"Wokke","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2016.12.004_bb0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/01.wnl.0000198776.53007.2c","article-title":"Course of disability and respiratory function in untreated late-onset Pompe disease","volume":"66","author":"Hagemans","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","article-title":"Pompe disease: a neuromuscular disease with respiratory muscle involvement","volume":"103","author":"Mellies","year":"2009","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/mus.24523","article-title":"Quantitative assessment of lingual strength in late-onset Pompe disease","volume":"51","author":"Jones","year":"2015","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mus.24437","article-title":"Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease","volume":"51","author":"Horvath","year":"2015","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","article-title":"Low bone mass in Pompe disease: muscular strength as a predictor of bone mineral density","volume":"47","author":"van den Berg","year":"2010","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5812\/ijem.4967","article-title":"Bone density in patients with late onset Pompe disease","volume":"10","author":"Papadimas","year":"2012","journal-title":"Int. J. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ymgme.2011.08.011","article-title":"The prevalence and impact of scoliosis in Pompe disease: lessons learned from the Pompe Registry","volume":"104","author":"Roberts","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0060","doi-asserted-by":"crossref","first-page":"963861","DOI":"10.1155\/2014\/963861","article-title":"Orthopedic management of patients with Pompe disease: a retrospective case series of 8 patients","volume":"2014","author":"Haaker","year":"2014","journal-title":"Sci. World J."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.c.31322","article-title":"Toward deconstructing the phenotype of late-onset Pompe disease","volume":"160C","author":"Schuller","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/ene.12582","article-title":"Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease","volume":"22","author":"Boentert","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0075","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ymgme.2012.05.007","article-title":"Autopsy findings in late-onset Pompe disease: a case report and systematic review of the literature","volume":"106","author":"Hobson-Webb","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2016.12.004_bb0080","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/14992027.2013.840932","article-title":"Prevalence of hearing loss in patients with late-onset Pompe disease: Audiological and otological consequences","volume":"52","author":"Hanisch","year":"2013","journal-title":"Int. J. Audiol."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3928\/01913913-20100106-08","article-title":"Clinical and histologic ocular findings in pompe disease","volume":"47","author":"Yanovitch","year":"2010","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"issue":"2-3","key":"10.1016\/j.ymgme.2016.12.004_bb0655","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0022-510X(90)90258-O","article-title":"Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency","volume":"98","author":"Kretzschmar","year":"1990","journal-title":"J. Neurol. Sci."},{"issue":"9-10","key":"10.1016\/j.ymgme.2016.12.004_bb0090","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients","volume":"17","author":"Muller-Felber","year":"2007","journal-title":"Neuromuscul. Disord."},{"issue":"2-3","key":"10.1016\/j.ymgme.2016.12.004_bb0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymgme.2010.06.003","article-title":"Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients","volume":"101","author":"Bernstein","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ymgme.2015.09.003","article-title":"Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining","volume":"117","author":"Jones","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000338776","article-title":"Incontinence in late-onset Pompe disease: an underdiagnosed treatable condition","volume":"68","author":"Remiche","year":"2012","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/8904_2014_381","article-title":"Expanding our understanding of lower urinary tract symptoms and incontinence in adults with pompe disease","volume":"20","author":"McNamara","year":"2015","journal-title":"JIMD Rep."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ymgme.2013.05.021","article-title":"Pain in adult patients with Pompe disease: a cross-sectional survey","volume":"109","author":"Gungor","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"9646","key":"10.1016\/j.ymgme.2016.12.004_bb0120","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Pompe's disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"issue":"1-2","key":"10.1016\/j.ymgme.2016.12.004_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2014.07.014","article-title":"Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry","volume":"113","author":"Kishnani","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0135","first-page":"5","article-title":"LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population","volume":"87","author":"Musumeci","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2013.03.002","article-title":"Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia","volume":"109","author":"Spada","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ymgme.2016.12.004_bb0145","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nmd.2015.04.008","article-title":"Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort","volume":"25","author":"Gutierrez-Rivas","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0150","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.0000000000002758","article-title":"Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness","volume":"87","author":"Lukacs","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.21376","article-title":"Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory","volume":"40","author":"Goldstein","year":"2009","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.ymgme.2016.12.004_bb0160","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet. Med."},{"issue":"5 Suppl","key":"10.1016\/j.ymgme.2016.12.004_bb0165","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","article-title":"Physical therapy management of Pompe disease","volume":"8","author":"Case","year":"2006","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/GIM.0b013e31819d0996","article-title":"Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease","volume":"11","author":"Nicolino","year":"2009","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.c.31321","article-title":"Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations","volume":"160C","author":"Case","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0185","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ymgme.2011.10.012","article-title":"Early cognitive development in children with infantile Pompe disease","volume":"105","author":"Spiridigliozzi","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ajmg.c.31323","article-title":"Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: long-term follow-up","volume":"160C","author":"Spiridigliozzi","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"7","key":"10.1016\/j.ymgme.2016.12.004_bb0195","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","article-title":"Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker","volume":"11","author":"Young","year":"2009","journal-title":"Genet. Med."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2016.12.004_bb0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2010.01.015","article-title":"Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: from our experience of 4 cases including an autopsy case","volume":"100","author":"Kobayashi","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"11","key":"10.1016\/j.ymgme.2016.12.004_bb0210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","article-title":"Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns","volume":"21","author":"Carlier","year":"2011","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mus.21393","article-title":"Diagnostic criteria for late-onset (childhood and adult) Pompe disease","volume":"40","author":"American Association of, N","year":"2009","journal-title":"Muscle Nerve"},{"issue":"24","key":"10.1016\/j.ymgme.2016.12.004_bb0220","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1212\/WNL.0000000000002772","article-title":"Teaching Video NeuroImages: The Beevor sign in late-onset Pompe disease","volume":"86","author":"Garibaldi","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ymgme.2016.12.004_bb0225","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nmd.2003.08.003","article-title":"Muscle MRI in Adult-Onset Acid Maltase Deficiency","volume":"14","author":"Pichiecchio","year":"2004","journal-title":"Neuromuscul. Disord."},{"issue":"8","key":"10.1016\/j.ymgme.2016.12.004_bb0235","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult-onset acid maltase deficiency in France Genotype\u2013phenotype correlation","volume":"55","author":"Laforet","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2016.12.004_bb0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgmr.2015.03.010","article-title":"Muscle imaging data in late-onset Pompe disease reveal a correlation between the pre-existing degree of lipomatous muscle alterations and the efficacy of long-term enzyme replacement therapy","volume":"3","author":"Gruhn","year":"2015","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1-2","key":"10.1016\/j.ymgme.2016.12.004_bb0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ymgme.2011.06.012","article-title":"Rate of progression and predictive factors for pulmonary outcome in children and adults with Pompe disease","volume":"104","author":"van der Beek","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2016.12.004_bb0250","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0255","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10554-015-0629-7","article-title":"Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult Pompe disease","volume":"31","author":"Morris","year":"2015","journal-title":"Int. J. Cardiovasc. Imaging"},{"issue":"15","key":"10.1016\/j.ymgme.2016.12.004_bb0260","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0265","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.wco.0000180662.03544.5f","article-title":"Respiratory function assessment and intervention in neuromuscular disorders","volume":"18","author":"Mellies","year":"2005","journal-title":"Curr. Opin. Neurol."},{"issue":"7","key":"10.1016\/j.ymgme.2016.12.004_bb0270","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.57.7.1290","article-title":"Sleep-disordered breathing and respiratory failure in acid maltase deficiency","volume":"57","author":"Mellies","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2016.12.004_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12890-015-0058-3","article-title":"Lung MRI and impairment of diaphragmatic function in Pompe disease","volume":"15","author":"Wens","year":"2015","journal-title":"BMC Pulm. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2016.12.004_bb0280","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/ajmg.a.37687","article-title":"Death from supine asphyxia in late onset pompe disease: Two patients","volume":"170","author":"Kansagra","year":"2016","journal-title":"Am. J. Med. Genet. A"},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0285","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mus.24142","article-title":"Motor function and respiratory capacity in patients with late-onset pompe disease","volume":"49","author":"Illes","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2016.12.004_bb0295","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880160614","article-title":"Adult acid maltase deficiency","volume":"16","author":"Barohn","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2016.12.004_bb0300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mus.21393","article-title":"Diagnostic criteria for late-onset (childhood and adult) Pompe disease","volume":"40","author":"AANEM","year":"2009","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.ymgme.2016.12.004_bb0305","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.clinph.2011.04.016","article-title":"The clinical and electrodiagnostic characteristics of Pompe disease with post-enzyme replacement therapy findings","volume":"122","author":"Hobson-Webb","year":"2011","journal-title":"Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0310","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nmd.2009.11.006","article-title":"Rigid spine syndrome revealing late-onset Pompe disease","volume":"20","author":"Laforet","year":"2010","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0315","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2015.09.001","article-title":"Characterization of gait in late onset Pompe disease","volume":"116","author":"McIntosh","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2016.12.004_bb0320","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mus.22202","article-title":"Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation","volume":"44","author":"Dubrovsky","year":"2011","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0325","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/brain\/91.3.435","article-title":"Adult myopathy from glycogen storage disease due to acid maltase deficiency","volume":"91","author":"Hudgson","year":"1968","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0330","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mus.880100311","article-title":"The pattern of involvement of adult-onset acid maltase deficiency at autopsy","volume":"10","author":"van der Walt","year":"1987","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0335","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00005792-199505000-00002","article-title":"Clinical variability in adult-onset acid maltase deficiency: report of affected sibs and review of the literature","volume":"74","author":"Felice","year":"1995","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0340","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nmd.2012.12.003","article-title":"Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement","volume":"23","author":"Hobson-Webb","year":"2013","journal-title":"Neuromuscul. Disord."},{"issue":"12","key":"10.1016\/j.ymgme.2016.12.004_bb0345","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/3.12.2231","article-title":"Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation","volume":"3","author":"Huie","year":"1994","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0350","first-page":"50","article-title":"Adult-onset acid maltase deficiency with prominent bulbar involvement and ptosis","volume":"86","author":"Barnes","year":"1993","journal-title":"J. R. Soc. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0355","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/WNO.0b013e3181f9a923","article-title":"Ptosis in Pompe disease: common genetic background in infantile and adult series","volume":"30","author":"Ravaglia","year":"2010","journal-title":"J. Neuroophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-015-0412-3","article-title":"Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group","volume":"15","author":"Jasmi","year":"2015","journal-title":"BMC Neurol."},{"issue":"12","key":"10.1016\/j.ymgme.2016.12.004_bb0365","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1212\/01.wnl.0000249183.39952.3e","article-title":"Ptosis as a feature of late-onset glycogenosis type II","volume":"67","author":"Groen","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0370","first-page":"219","article-title":"Rigid spine syndrome: a muscle syndrome in search of a name","volume":"66","author":"Dubowitz","year":"1973","journal-title":"Proc. R. Soc. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0375","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-4598(199703)20:3<364::AID-MUS16>3.0.CO;2-0","article-title":"The rigid spine syndrome due to acid maltase deficiency","volume":"20","author":"Fadic","year":"1997","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0380","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nmd.2006.02.001","article-title":"Juvenile onset acid maltase deficiency presenting as a rigid spine syndrome","volume":"16","author":"Kostera-Pruszczyk","year":"2006","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0385","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jc.2014-2763","article-title":"Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease","volume":"100","author":"Bertoldo","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0390","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2010.09.002","article-title":"Body composition analysis in late-onset Pompe disease","volume":"102","author":"Papadimas","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0395","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1748-7161-3-14","article-title":"A Dutch guideline for the treatment of scoliosis in neuromuscular disorders","volume":"3","author":"Mullender","year":"2008","journal-title":"Scoliosis"},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0400","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ocl.2007.07.001","article-title":"New strategies and decision making in the management of neuromuscular scoliosis","volume":"38","author":"Sarwark","year":"2007","journal-title":"Orthop. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0405","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1359\/JBMR.051201","article-title":"Hyperkyphotic posture and risk of future osteoporotic fractures: the Rancho Bernardo study","volume":"21","author":"Huang","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0410","doi-asserted-by":"crossref","first-page":"196","DOI":"10.12659\/AJCR.893309","article-title":"Small-fiber neuropathy in pompe disease: first reported cases and prospective screening of a clinic cohort","volume":"16","author":"Hobson-Webb","year":"2015","journal-title":"Am. J. Case Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mus.10181","article-title":"Small-fiber neuropathy","volume":"26","author":"Lacomis","year":"2002","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0420","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/mus.23757","article-title":"Cramps and small-fiber neuropathy","volume":"48","author":"Lopate","year":"2013","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.ymgme.2016.12.004_bb0425","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0887-8994(86)90075-5","article-title":"Quantitative histological study of the sural nerve in a child with acid maltase deficiency (glycogenosis type II)","volume":"2","author":"Origuchi","year":"1986","journal-title":"Pediatr. Neurol."},{"issue":"1-2","key":"10.1016\/j.ymgme.2016.12.004_bb0430","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2010.10.031","article-title":"Late form of Pompe disease with glycogen storage in peripheral nerves axons","volume":"301","author":"Fidzianska","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0435","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ymgme.2012.07.024","article-title":"Auditory system involvement in late onset Pompe disease: a study of 20 Italian patients","volume":"107","author":"Musumeci","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0445","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.surneu.2007.05.049","article-title":"Thrombotic complications of a basilar artery aneurysm in a young adult with Pompe disease","volume":"70","author":"Refai","year":"2008","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0450","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2147\/NDT.S94892","article-title":"Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report","volume":"12","author":"Zhang","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"22","key":"10.1016\/j.ymgme.2016.12.004_bb0455","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/01.wnl.0000313367.09469.13","article-title":"Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease","volume":"70","author":"Laforet","year":"2008","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ymgme.2016.12.004_bb0460","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s00415-010-5618-0","article-title":"Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease","volume":"257","author":"Sacconi","year":"2010","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0465","first-page":"82","article-title":"Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe's disease: a case report","volume":"7","author":"Sandhu","year":"2014","journal-title":"J. Vasc. Interv. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0470","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00415-015-7664-0","article-title":"Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment","volume":"262","author":"Montagnese","year":"2015","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0475","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000087710","article-title":"The Natural History of Radiographically Defined Vertebrobasilar Nonsaccular Intracranial Aneurysms","volume":"20","author":"Flemming","year":"2005","journal-title":"Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0480","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410220512","article-title":"Alpha-glucosidase deficiency and basilar artery aneurysm: report of a sibship","volume":"22","author":"Makos","year":"1987","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0485","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ymgme.2011.04.009","article-title":"Expanding the clinical spectrum of late-onset Pompe disease: dilated arteriopathy involving the thoracic aorta, a novel vascular phenotype uncovered","volume":"103","author":"El-Gharbawy","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0490","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mus.880181414","article-title":"Glycogenosis type II (acid maltase deficiency)","volume":"3","author":"Reuser","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2016.12.004_bb0495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1289\/ehp.7826169","article-title":"Myocardial metabolism for the toxicologist","volume":"26","author":"Merin","year":"1978","journal-title":"Environ. Health Perspect."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0500","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2796.2008.01966.x","article-title":"Cardiac involvement in adults with Pompe disease","volume":"264","author":"Soliman","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0505","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/GIM.0b013e3182142966","article-title":"Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy","volume":"13","author":"Forsha","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0510","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2016_563","article-title":"Severe Cardiomyopathy as the Isolated Presenting Feature in an Adult with Late-Onset Pompe Disease: A Case Report","author":"Mori","year":"2016","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0515","first-page":"205","article-title":"The Mount Sinai Hospital clinicalpathological conference: a 45-year-old man with Pompe's disease and dilated cardiomyopathy","volume":"68","author":"Ben-Ami","year":"2001","journal-title":"Mt Sinai J. Med."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0520","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/8904_2014_339","article-title":"Hypertrophic cardiomyopathy in pompe disease is not limited to the classic infantile-onset phenotype","volume":"17","author":"Lee","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0525","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0929-693X(01)00968-X","article-title":"Familial hypertrophic cardiomyopathy associated with Wolff-Parkinson-White syndrome revealing type II glycogenosis","volume":"9","author":"Tabarki","year":"2002","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.ymgme.2016.12.004_bb0530","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2008.07.013","article-title":"Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities","volume":"275","author":"Van der Beek","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"22","key":"10.1016\/j.ymgme.2016.12.004_bb0535","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","article-title":"Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy","volume":"107","author":"Arad","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0540","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0002-8703(78)90093-5","article-title":"Pompe's disease presenting as hypertrophic myocardiopathy with Wolff-Parkinson-White syndrome","volume":"96","author":"Bulkley","year":"1978","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0545","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/etm.2015.2862","article-title":"Infantile Pompe disease: A case report and review of the Chinese literature","volume":"11","author":"Liu","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0550","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/mus.24618","article-title":"Fibromyalgia-like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late-onset Pompe disease","volume":"52","author":"Gesquiere-Dando","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2016.12.004_bb0555","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/8904_2014_334","article-title":"Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectional survey","volume":"17","author":"Karabul","year":"2014","journal-title":"JIMD Rep."},{"issue":"1-2","key":"10.1016\/j.ymgme.2016.12.004_bb0560","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jns.2015.04.012","article-title":"Gastrointestinal symptoms in late-onset Pompe disease: Early response to enzyme replacement therapy","volume":"353","author":"Pardo","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.ymgme.2016.12.004_bb0565","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Investig."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0570","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0025-7753(03)73601-X","article-title":"Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain","volume":"120","author":"Badia","year":"2003","journal-title":"Med. Clin. (Barc.)"},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0575","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijcard.2014.04.270","article-title":"International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP\/NICOR, SWEDEHEART\/RIKS-HIA, and ACTION Registry-GWTG\/NCDR registries","volume":"175","author":"McNamara","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0580","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3999(03)00371-4","article-title":"The assessment of fatigue: a practical guide for clinicians and researchers","volume":"56","author":"Dittner","year":"2004","journal-title":"J. Psychosom. Res."},{"issue":"9413","key":"10.1016\/j.ymgme.2016.12.004_bb0585","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(04)15794-2","article-title":"Fatigue in neurological disorders","volume":"363","author":"Chaudhuri","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ymgme.2016.12.004_bb0590","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.acn.2005.04.002","article-title":"An examination of four models predicting fatigue in multiple sclerosis","volume":"20","author":"Strober","year":"2005","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"3","key":"10.1016\/j.ymgme.2016.12.004_bb0595","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/01.psy.0000124757.10167.b1","article-title":"Temporal relations between unexplained fatigue and depression: longitudinal data from an international study in primary care","volume":"66","author":"Skapinakis","year":"2004","journal-title":"Psychosom. Med."},{"issue":"11","key":"10.1016\/j.ymgme.2016.12.004_bb0600","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/WNL.0b013e31821043a4","article-title":"Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom","volume":"76","author":"Brusse","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0605","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","article-title":"Depression in multiple sclerosis: a review","volume":"76","author":"Siegert","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0610","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ymgme.2013.03.016","article-title":"Enzyme replacement therapy and fatigue in adults with Pompe disease","volume":"109","author":"Gungor","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0615","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the Hospital Anxiety and Depression Scale. An updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J. Psychosom. Res."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0620","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/mus.22296","article-title":"How common is misdiagnosis in late-onset Pompe disease?","volume":"45","author":"Hobson-Webb","year":"2012","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.ymgme.2016.12.004_bb0625","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.410090618","article-title":"Adult-onset acid maltase deficiency presenting as diaphragmatic paralysis","volume":"9","author":"Sivak","year":"1981","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.ymgme.2016.12.004_bb0630","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/milmed\/163.10.715","article-title":"A 60-year-old woman with weakness, fatigue, and acute respiratory failure: case report and discussion of the differential diagnosis","volume":"163","author":"Sander","year":"1998","journal-title":"Mil. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2016.12.004_bb0635","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000334398","article-title":"Late onset glycogen storage disease type II: pitfalls in the diagnosis","volume":"67","author":"Papadimas","year":"2012","journal-title":"Eur. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0640","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/mus.23643","article-title":"Pompe disease, the must-not-miss diagnosis: A report of 3 patients","volume":"47","author":"Dubrovsky","year":"2013","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ymgme.2016.12.004_bb0645","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1212\/WNL.23.1.95","article-title":"The spectrum and diagnosis of acid maltase deficiency","volume":"23","author":"Engel","year":"1973","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ymgme.2016.12.004_bb0650","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ymgme.2015.02.004","article-title":"Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and\/or hyperCKemia","volume":"114","author":"Perez-Lopez","year":"2015","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216302967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216302967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T12:02:41Z","timestamp":1568635361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719216302967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1096719216302967"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.12.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging phenotype of late-onset Pompe disease: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}